Congenital heart disease medical therapy

Revision as of 15:35, 4 October 2012 by Michael Maddaleni (talk | contribs) (Created page with "__NOTOC__ {{Congenital heart disease}} {{CMG}} ==Overview== ==ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. (DO NOT EDIT)<ref name="pm...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Congenital heart disease Microchapters

Home

Patient Information

Overview

Anatomy

Classification

Pathophysiology

Causes

Differentiating Congenital heart disease from other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography

Prenatal Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Prevention

Outcomes

Reproduction

Case Studies

Case #1

Congenital heart disease medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Congenital heart disease medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Congenital heart disease medical therapy

CDC on Congenital heart disease medical therapy

Congenital heart disease medical therapy in the news

Blogs on Congenital heart disease medical therapy

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Congenital heart disease medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. (DO NOT EDIT)[1]

Recommendations for Medical Therapy

Class I
"1. Cardioversion after appropriate anticoagulation is recommended to attempt restoration of the sinus rhythm if atrial fibrillation occurs. (Level of Evidence: A) "
"2. Rate control and anticoagulation are recommended if sinus rhythm cannot be maintained by medical or interventional means. (Level of Evidence: A)"

References

  1. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.